Source: The journal of clinical endocrinology & metabolism. Unidade: FM
Subjects: FIBROBLASTOS, CÁLCIO (DEFICIÊNCIA), DOENÇAS CARDIOVASCULARES, MUTAÇÃO GENÉTICA, FATORES DE CRESCIMENTO, BIOLOGIA MOLECULAR, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONUCHIC, Laura et al. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with jansen's metaphyseal chondrodysplasia. The journal of clinical endocrinology & metabolism, v. 97, n. 4, p. 1098-1103, 2012Tradução . . Disponível em: https://doi.org/10.1210/jc.2011-3082. Acesso em: 16 nov. 2024.APA
Onuchic, L., Souza, B. F. de, Mendonca, B. B., Correa, P. H. S., & Martin, R. M. (2012). Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with jansen's metaphyseal chondrodysplasia. The journal of clinical endocrinology & metabolism, 97( 4), 1098-1103. doi:10.1210/jc.2011-3082NLM
Onuchic L, Souza BF de, Mendonca BB, Correa PHS, Martin RM. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with jansen's metaphyseal chondrodysplasia [Internet]. The journal of clinical endocrinology & metabolism. 2012 ; 97( 4): 1098-1103.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1210/jc.2011-3082Vancouver
Onuchic L, Souza BF de, Mendonca BB, Correa PHS, Martin RM. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with jansen's metaphyseal chondrodysplasia [Internet]. The journal of clinical endocrinology & metabolism. 2012 ; 97( 4): 1098-1103.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1210/jc.2011-3082
